DChirnoaga
ActiveSummary
DChirnoaga has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1k and a net result of €210k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
57
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency25▼-64
Growth58▼-20
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
0.2%
Return on assets
41.9%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 5%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
63 d early
2024
39 d late
2023
30 d late
2022
14 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€1k▼ 99.8%
2024 · €429k
2022: €126k
2023: €324k
2024: €429k
2022 → 2025
Total assets
€502k▼ 25.1%
2024 · €670k
2022: €172k
2023: €429k
2024: €670k
2022 → 2025
Net result
€210k▲ 1.0%
2024 · €208k
2022: €125k
2023: €198k
2024: €208k
2022 → 2025
Working capital
€-23k
2024 · €400k
2022: €119k
2023: €318k
2024: €400k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€126k-€324k▲ 157%€429k▲ 32.2%€1k▼ 99.8%
Operating result€160k-€250k▲ 56.4%€253k▲ 1.0%€264k▲ 4.6%
Net result€125k-€198k▲ 58.1%€208k▲ 5.0%€210k▲ 1.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen three years in a row; 2025 is 5% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €502k
Fixed assets
€87k ▼ 23.1%
Current assets
€415k ▼ 25.5%
Equity and liabilities €502k
Equity
€1k ▼ 99.8%
Debt
€501k ▲ 108%
Debt's share of the balance-sheet total rises from 35.9% to 99.8%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€290k▲
2024 · €263k
Cash flow
€236k▲
2024 · €218k
Current ratio
0.95▼
2024 · 3.55
ROA
41.9%▲
2024 · 31.1%
Interest coverage
71.66▼
2024 · 148.45
Debt ≤ 1 year
€438k▲
2024 · €157k
Debt > 1 year
€63k▼
2024 · €84k
Income taxes
€71k▲
2024 · €65k
A ratio outside any meaningful range has been withheld (balance sheet total €502k, equity €1k).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 41 lines
Balance sheet
Code20242025
Assets
Total assets20/58€670k€502k▼
Fixed assets21/28€113k€87k▼
Tangible fixed assets22/27€113k€87k▼
Plant, machinery and equipment23€2k€1k▼
Furniture and vehicles24€111k€86k▼
Current assets29/58€557k€415k▼
Amounts receivable within one year40/41€502k€374k▼
Trade receivables40€53k€42k▼
Other amounts receivable41€449k€332k▼
Cash at bank and in hand54/58€52k€39k▼
Deferred charges and accrued income490/1€3k€2k▼
Equity and liabilities
Total equity and liabilities10/49€670k€502k▼
Equity10/15€429k€1k▼
Contributions10/11€1k€1k=
Profit (loss) carried forward14€428k-
Amounts payable17/49€241k€501k▲
Amounts payable after more than one year17€84k€63k▼
Financial debts170/4€84k€63k▼
Amounts payable within one year42/48€157k€438k▲
Current portion of amounts payable after more than one year42€21k€21k▲
Trade debts44€7k-
Suppliers440/4€7k-
Taxes, remuneration and social security45€129k€139k▲
Taxes450/3€129k€139k▲
Other amounts payable47/48-€278k
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€26k▲
Other operating charges640/8€195€444▲
Gross operating margin9900€263k€291k▲
Operating profit (loss)9901€253k€264k▲
Financial income75/76B€22k€21k▼
Recurring financial income75€22k€21k▼
Financial charges65/66B€2k€4k▲
Recurring financial charges65€2k€4k▲
Profit (loss) for the period before taxes9903€273k€281k▲
Income taxes67/77€65k€71k▲
Profit (loss) for the period9904€208k€210k▲
Profit (loss) for the period to be appropriated9905€208k€210k▲
Appropriation of the result
Profit (loss) to be appropriated9906€531k€638k▲
Profit (loss) brought forward from the previous period14P€323k€428k▲
Profit to be distributed694/7€103k€638k▲
Return on contributions (dividend)694€103k€638k▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2022net €210k ▲1%
Operating result €264k, net result €210k, both a record.
08-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 39 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Equity above €200kEq €324k ▲157%
2 profitable years in a row build equity to €324k.
17-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Joost-ten-Node · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Warmoesstraat 1571210 Sint-Joost-ten-NodeGround area
847 m²
Building footprint
58 m²
Volume, LiDAR
741 m³
Parcel 21572B0003/00Y006, Brussels · tallest building 17.3 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
DChirnoaga
since 20222.336.707.333
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21572B0003/00Y006 | Brussels | 847 m² | 1 · 58 m² | 17.3 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr Karolien Verhaeghe - Anesthesie
BE 0645.723.258
Wemmel · Eq €1,000
Drs. Noyez-Dom
BE 0726.603.442
Sint-Katelijne-Waver · Eq €1,000
DOKTER CARESSA MEERT, HEMATOLOOG
BE 0726.852.870
Destelbergen · Eq €1,000
Drs. Borgers-De Rijdt MD Orthopedie - Fertiliteit
BE 0731.589.341
Schoten · Eq €1,000
DR. WAELBERS
BE 0732.933.681
Mechelen · Eq €1,000
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 552 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded03-02-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.